- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06579625
The Effect of Health Belief Model-Based Cancer Education on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings
The Effect of Health Belief Model-Based Cancer Education Given to Caregivers of Cancer Patients on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cancer is a significant public health issue with high morbidity and mortality rates worldwide and in our country. According to cancer statistics published by the World Health Organization's International Agency for Research on Cancer, the number of people diagnosed with cancer increases every year. In 2022, the global number of new cancer cases was 20 million, and it is estimated to reach 32.6 million by 2045. Cancer ranks second among all causes of death globally and in Turkey, with approximately one in every six individuals succumbing to cancer according to WHO estimates. The increasing number of cancer cases day by day unders cores the importance of cancer as it exerts physical, emotional, and financial pressure on individuals, families, and society and is a significant cause of death.
In secondary prevention methods for cancer prevention, early diagnosis and screening programs encompass the diagnosis and treatment of the disease before it progresses. In our country, cancer screenings include breast cancer, cervical cancer, and colon cancer screenings. It is important to raise awareness in the community about early diagnosis and screening programs for cancer. All individuals in the society should learn the causes, risk factors, and symptoms of cancer from accurate and reliable sources. Research results indicate that participants knowledge about cancer screenings is not at a sufficient level. With the high prevalence of cancer in society, individuals are increasingly seeking information about cancer. However, as knowledge about cancer increases, individuals may experience information overload, which can lead to confusion. Studies have shown that as the burden of cancer knowledge increases, individuals tend to avoid cancer-related information and engage in fewer health-protective, preventive behaviors.
The Health Belief Model pos its that individuals health behaviors are influenced by beliefs, values, and attitudes and is frequently used in health education. The primary aim of the Health Belief Model is to understand what motivates individuals to engage in preventive behaviors, to undergo health screenings forearly diagnosis, and to control the in diseases, and to develop interventions tailored to the individual. This study aims to evaluate the effect of cancer educati on based on the Health Belief Model on the knowled geand attitudes towards cancer screenings among caregivers of cancer patients.
The population of the study consists of individual sproviding care to cancer patients who have agreed to participate in the research, aged between 30 and 70 years, literate, and with out anyyisual, auditory, intellectual, or orthopedic impairments. Th eincluded individuals (78 caregivers) will be stratified by the clinics where they provide care and weighted according to the number of inpatients they carefor. The experimental and control groups will be listed and numbered separately for each clinic, and random sampling will be conducted using a real random number generator (https://www.random.org/). Random selections will be planned sequentially, with one experimental and one control group alternately. Selection will continue until the sample size is reached. As part of thepre-test, the introductory information form, Cancer Knowledge Scale, Cancer Screening Knowledge Scale, and Cancer Screening Attitude Scale will be administered to individuals in both the experimental and control groups. The experimental group will receive a 4-week cancer education program based on the Health Belief Model, while no interventi on will be made for the control group. As part of the post-test, the Cancer Knowledge Scale, Cancer Screening Knowledge Scale, and Cancer Screening Attitude Scale will be administered to both the experimental and control groups. Data analysis will be performed using the Statistical Package for Social Sciences (SPSS) 25.0 program.
Cancer screenings ensure the early detection of cancer. Cancers diagnosed in the early stages are easier, faster, and more cost-effective to cure and treat compared to advanced-stage cancers. This study may provide guid an ceto caregivers of cancer patients by increasing their knowledge about cancer and cancer screening programs, reducing the burden of cancer knowledge, and increasing participation rates in screenin gprograms. Additionally, this study may shed light on the impact of cancer education on cancer knowledge, screening knowledge, and attitudes among individuals with different demographic characteristics.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Semanur AKER
- Phone Number: +90 05065448466
- Email: semaakeer@gmail.com
Study Locations
-
-
-
Ankara, Turkey, 06200
- Dr. Abdurrhman Yurtaslan Oncology Education and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals who agree to participate in the study, are aged 30-70,
- Are literate,
- Do not have any auditory, visual, cognitive, or orthopedic disabilities that would prevent participation,
- Are not receiving palliative care services, will be included. This includes caregivers of cancer patients.
Exclusion Criteria:
- Individuals under the age of 30 or over the age of 70,
- Those who are illiterate,
- Those with disabilities that would prevent participation in the study,
- Those who provide care for cancer patients receiving palliative care services will not be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group will not receive any intervention.
|
|
|
Other: experimental group
The effect of cancer education on cancer knowledge burden, information about cancer screenings, and attitudes will be evaluated by providing cancer education to 39 patients in the experimental group.
|
Participants in the experimental group will receive cancer education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
İnformation Towards Cancer Screening Scale
Time Frame: one month
|
The scale consists of 15 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: "5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree." The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 15 and the highest is 75. There is no specific cutoff point for the scale. Scores close to 15 indicate |
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cancer Knowledge Burden
Time Frame: one month
|
Cancer information overload was measured using a thirteen- item battery assessing feelings about the overwhelming quantity of cancer information.
Four response options (strongly disagree to strongly agree) were provided for each item (i.e., higher scores for greater overload).
Items were crafted based on HINTS questions, an explication of the construct (detailed in the literature review of this article), and formative research conducted by the authors.
|
one month
|
|
Attitudes Towards Cancer Screening Scale
Time Frame: one mounth
|
The scale consists of 24 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: "5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree." The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 24 and the highest is 120. There is no specific cutoff point for the scale. Scores close to 24 indicat |
one mounth
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AnkaraU-HEM-SA-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Cancer education
-
Duke UniversityCancer and Leukemia Group B; Durham VA Medical CenterCompletedSmoking Cessation | Tobacco Use Disorder | Lung CancerUnited States
-
Toros UniversityNot yet recruitingCervical Cancer Screening | Breast Cancer Screening | Colorectal Cancer Screening | Cancer Prevention Behavior
-
National Cheng Kung UniversityCompleted
-
Thaddeus PaceCompletedCancer Survivors | Informal Cancer Caregivers (Family and Friends of Cancer Survivors)United States
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
University of North Carolina, Chapel HillNational Cancer Institute (NCI); Duke UniversityCompletedEarly-Stage Breast CancerUnited States
-
Istanbul Aydın UniversityActive, not recruiting
-
University of California, DavisCalifornia Academy of Family PhysiciansCompletedColorectal NeoplasmsUnited States
-
Inonu UniversityCompletedBeing Literate | Not Having Any Cognitive, Visual or Orthopedic Disabilities | Being Between the Ages of 50-65 | Having a Smart Phone | The Effect of Education on Cancer Screening on the Knowledge Level of Women | The Effect of Education on Cancer Screening on Women&Amp;#39;s Attitudes | The Effect...Turkey (Türkiye)